Key research area | Knowledge Gap on extra-genital CT and NG infections in women and MSM |
Morbidity | Proctitis in anorectal infections |
 | Reproductive morbidity (women) |
Efficacy control strategies: Treatment | Efficacy of treatment for both extra-genital and genital infections and associated factors (including treatment resistance, tissue absorption, duration of treatment to account for CT life cycle phases) |
Efficacy control strategies: Re-testing, partner management | Efficacy of strategies to manage extra-genital infections (including strategies that are already taken to manage genital infections) |
Transmission | Transmission risk between sexual partners and associated factors, such as bacterial load, sexual behavior |
 | Self-infection, i.e. transmission risk between anatomic sites within a patient and associated factors, i.e. bacterial load, sexual behavior (women) |
 | Role in the transmission of other STI including HIV |
Detection | Microbiologic specifics of a CT - NAAT detection such as bacterial load, viability or other possible markers of transmission or of morbidity |
Testing policy | Cost effectiveness of extra-genital CT and NG testing taking into account the key research area’s of efficacy of extra-genital control-strategies, transmission and morbidity |